Allarity Therapeutics develops cancer treatments, mainly stenoparib, and a companion diagnostic test to identify patients likely to benefit from them. It last closed at $0.84 on Nov 17, down 3.91% on the day.
Only 1 firm rated ALLR in the past 90 days, not enough for a consensus
Average 12-month target
$11.25
▲ 1237.7% upside
Based on 1 analyst who set a price target on ALLR in the past 90 days. The average target is $11.25, with a high of $11.25 and a low of $11.25, compared with the last close of $0.84.
Low $11.25Avg $11.25High $11.25
Blue marker: last close $0.84
Highest target$11.25
Average target$11.25
Lowest target$11.25
Latest rating changes
Ascendiant CapitalTarget raised
Nov 17Buy$11 → $11.25
Ascendiant CapitalTarget raised
Sep 16Buy$10.25 → $11
Ascendiant CapitalMaintained
Jun 8Buy$10.25
Date
Firm
Action
Rating
Price target
Nov 17
Ascendiant Capital
Target raised
Buy
$11 → $11.25
Sep 16
Ascendiant Capital
Target raised
Buy
$10.25 → $11
Jun 8
Ascendiant Capital
Maintained
Buy
$10.25
Loading…
Technical Analysis
ALLR · as of the Nov 17 close · updated after every close
Downtrend
The stock is 11% below its 20 day and 18% below its 50 day average. It is 44% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 40). The nearest support is the Pivot S1 at $0.81, and the nearest resistance the Pivot at $0.85.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 10.1%/day
Key levels
$1.8452 week high+119.0%
$1.21200 day average+44.0%
$1.15100 day average+36.9%
$0.9950 day average+17.9%
$0.9320 day average+10.7%
$0.92Swing high (Oct 16)+9.5%
$0.88Pivot R1+4.8%
$0.85Pivot+1.2%
$0.84Last close
$0.81Pivot S1−3.6%
$0.80Swing low (Oct 15)−4.8%
$0.7752 week low−8.3%
Indicators
RSI (14)
39.97
Weak, oversold below 30
Neutral
MACD
-0.02
Below its signal line
Bearish
Stochastic
17.8
Near the bottom of its range
Oversold
ADX (14)
17.7
No clear trend
Williams %R
-92.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
-121.5
Oversold below −100, overbought above 100
Oversold
Rate of change
−25.6%
Change over 10 sessions
Bearish
ATR (14)
$0.09
Typical daily range, 10.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityLow, 40.4%/day
Key levels
$1.8452 week high+119.0%
$1.21200 day average+44.0%
$1.15100 day average+36.9%
$0.9950 day average+17.9%
$0.9320 day average+10.7%
$0.92Swing high (Oct 16)+9.5%
$0.88Pivot R1+4.8%
$0.85Pivot+1.2%
$0.84Last close
$0.81Pivot S1−3.6%
$0.80Swing low (Oct 15)−4.8%
$0.7752 week low−8.3%
Indicators
RSI (14)
28.68
Oversold below 30
Oversold
MACD
-0.32
Above its signal line
Bullish
Stochastic
15.9
Near the bottom of its range
Oversold
ADX (14)
6.5
No clear trend
Williams %R
-94.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-104.5
Oversold below −100, overbought above 100
Oversold
Rate of change
−31.1%
Change over 10 sessions
Bearish
ATR (14)
$0.34
Typical daily range, 40.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for ALLR
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ALLR did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow ALLR usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How ALLR has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ALLR is in one of them and how their past ALLR trades turned out.
Allarity Therapeutics is a pharmaceutical company based in Boston, Massachusetts, that develops cancer treatments. Its main focus is stenoparib, a therapy being studied in ovarian cancer and small cell lung cancer. The company also develops its Drug Response Predictor platform, a companion diagnostic designed to identify which patients are most likely to benefit from a particular cancer drug.